Form 4: Lexicon Pharmaceuticals Executive Exercises Stock Options, Disposes of Shares for Tax Obligations
SEC Form 4 Filing
Craig B. Granowitz, SVP and Chief Medical Officer of Lexicon Pharmaceuticals, exercised stock options and disposed of shares to cover tax obligations on February 28, 2025.
Summary
- On February 28, 2025, Craig B. Granowitz, SVP and Chief Medical Officer of Lexicon Pharmaceuticals, exercised restricted stock units, converting them into common stock.
- He acquired 27,917, 35,790 and 74,227 shares of common stock through the exercise of these units.
- Following these transactions, Granowitz directly owns 120,252 shares of Lexicon Pharmaceuticals common stock.
- A total of 65,308 shares were disposed of to satisfy tax withholding obligations at a price of $0.67 per share.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of transaction: Exercise of restricted stock units and disposal of shares for tax obligations. |
| 03/03/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.